{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:35:55Z","timestamp":1791866155677,"version":"4.3.4"},"reference-count":133,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Epithelial ovarian cancer (EOC) is a heterogeneous group of malignancies, including high-grade serous ovarian cancer (HGSC). HGSC is often diagnosed at advanced stages and is linked to TP53 variants. While BRCA variants elevate risk, most HGSC cases occur in individuals without known genetic variants, necessitating prevention strategies for people without known high-risk genetic variants. Effective prevention programs are also needed due to the lack of traditional screening options. An emerging primary prevention strategy is opportunistic salpingectomy, which involves removing fallopian tubes during another planned pelvic surgery. Opportunistic salpingectomy offers a safe and cost-effective preventative option that is gaining global adoption. With the publication of the first cohort study of patients who underwent salpingectomy, specifically for cancer prevention, attention has turned to broadening opportunities for salpingectomy in addition to more targeted approaches. Prevention opportunities are promising with increasing adoption of salpingectomy and the increased understanding of the etiology of the distinct histotypes of ovarian cancer. Yet, further research on targeted risk-reducing salpingectomy with thoughtful consideration of equity is necessary to reduce death and suffering from ovarian cancer.<\/jats:p>","DOI":"10.3390\/curroncol30120741","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:34:10Z","timestamp":1701304450000},"page":"10179-10194","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs"],"prefix":"10.3390","volume":"30","author":[{"given":"Ramlogan","family":"Sowamber","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"},{"name":"Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9661-7790","authenticated-orcid":false,"given":"Alexandra","family":"Lukey","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Huntsman","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"},{"name":"Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V6T 1Z4, Canada"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Hanley","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"ref_1","unstructured":"(2023, September 02). American Cancer Society Key Statistics for Ovarian Cancer. Available online: https:\/\/www.cancer.org\/content\/dam\/CRC\/PDF\/Public\/8773.00.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in Tumor Type in Low-Stage Versus High-Stage Ovarian Carcinomas","volume":"29","author":"Kalloger","year":"2010","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2013.03.021","article-title":"Ovarian Surface Epithelium as a Source of Ovarian Cancers: Unwarranted Speculation or Evidence-Based Hypothesis?","volume":"130","author":"Auersperg","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer Statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA. Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking Ovarian Cancer II: Reducing Mortality from High-Grade Serous Ovarian Cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The Distal Fallopian Tube: A New Model for Pelvic Serous Carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular Analysis of High-Grade Serous Ovarian Carcinoma with and without Associated Serous Tubal Intra-Epithelial Carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2016.11.039","article-title":"Of Mice and Women\u2014Non-Ovarian Origins of \u201cOvarian\u201d Cancer","volume":"144","author":"Karnezis","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2016.00108","article-title":"Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention","volume":"6","author":"George","year":"2016","journal-title":"Front. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.7150\/jca.30410","article-title":"BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance","volume":"10","author":"Gorodetska","year":"2019","journal-title":"J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas","volume":"20","author":"Pennington","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.annonc.2021.11.013","article-title":"European Experts Consensus: BRCA\/Homologous Recombination Deficiency Testing in First-Line Ovarian Cancer","volume":"33","author":"Vergote","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41698-023-00402-y","article-title":"HRD Effects on First-Line Adjuvant Chemotherapy and PARPi Maintenance Therapy in Chinese Ovarian Cancer Patients","volume":"7","author":"Li","year":"2023","journal-title":"Npj Precis. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Heitz, F., Ataseven, B., Staniczok, C., Denkert, C., Rhiem, K., Hahnen, E., Heikaus, S., Moubarak, M., Welz, J., and Dagres, T. (2023). Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer. Cancers, 15.","DOI":"10.3390\/cancers15030818"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2022.01.037","article-title":"Cracking the Homologous Recombination Deficiency Code: How to Identify Responders to PARP Inhibitors","volume":"166","author":"Paulet","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","article-title":"Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention","volume":"5","author":"Hanley","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population Distribution of Lifetime Risk of Ovarian Cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian Cancer Population Screening and Mortality after Long-Term Follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","article-title":"Ovarian Cancer Prevention and Screening","volume":"131","author":"Menon","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.annonc.2023.05.005","article-title":"Olaparib plus Bevacizumab First-Line Maintenance in Ovarian Cancer: Final Overall Survival Results from the PAOLA-1\/ENGOT-Ov25 Trial","volume":"34","author":"Leary","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1758834012467661","article-title":"Bevacizumab and Ovarian Cancer","volume":"5","author":"Garcia","year":"2013","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"m3773","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of Epithelial Ovarian Cancer","volume":"9","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/annonc\/mdt475","article-title":"New Developments in the Treatment of Ovarian Cancer-Future Perspectives","volume":"24","author":"Lopez","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_27","unstructured":"Miller, D., and Finlayson, S. (2023, August 10). Preventing Ovarian Cancer. OVCARE Res. Program. Vanc. Available online: http:\/\/www.ovcare.ca\/prevention\/preventing_ovarian_cancer\/."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic Changes in Prophylactically Removed Fallopian Tubes of Women Predisposed to Developing Ovarian Cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1998.5275","article-title":"The Cell of Origin of Ovarian Epithelial Tumors and the Ovarian Surface Epithelium Dogma: Does the Emperor Have No Clothes?","volume":"72","author":"Dubeau","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the Recognition of Tubal Intraepithelial Carcinoma: Applications to Cancer Screening and the Pathogenesis of Ovarian Cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv. Anat. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women with Familial Ovarian Cancer Syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A Candidate Precursor to Pelvic Serous Cancer (P53 Signature) and Its Prevalence in Ovaries and Fallopian Tubes from Women with BRCA Mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 Mutations in Serous Tubal Intraepithelial Carcinoma and Concurrent Pelvic High-Grade Serous Carcinoma-Evidence Supporting the Clonal Relationship of the Two Lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2008.07.018","article-title":"Risk Factors for a Serous Cancer Precursor (\u201cP53 Signature\u201d) in Women with Inherited BRCA Mutations","volume":"111","author":"Saleemuddin","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2212","article-title":"A Candidate Precursor to Serous Carcinoma That Originates in the Distal Fallopian Tube (J Pathol 2007; 211: 26\u201335)","volume":"213","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tube","volume":"8","author":"Papp","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous Tubal Intraepithelial Carcinoma: Diagnostic Reproducibility and Its Implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features: A Reproducibility Study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long Term Follow up of BRCA1 and BRCA2 Mutation Carriers with Unsuspected Neoplasia Identified at Risk Reducing Salpingo-Oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2012.06.015","article-title":"Tubal Epithelial Lesions in Salpingo-Oophorectomy Specimens of BRCA-Mutation Carriers and Controls","volume":"127","author":"Mingels","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-021-03244-w","article-title":"Recommendations for Diagnosing STIC: A Systematic Review and Meta-Analysis","volume":"480","author":"Bogaerts","year":"2022","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous Tubal Intraepithelial Carcinoma (STIC)\u2014Clinical Impact and Management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate Serous Cancer Precursors in Fallopian Tube Epithelium of BRCA1\/2 Mutation Carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00428-016-1928-7","article-title":"Serous Tubal Intraepithelial Carcinoma, Chronic Fallopian Tube Injury, and Serous Carcinoma Development","volume":"468","author":"Malmberg","year":"2016","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000369","article-title":"Evidence for a Dualistic Model of High-Grade Serous Carcinoma: BRCA Mutation Status, Histology, and Tubal Intraepithelial Carcinoma","volume":"39","author":"Howitt","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1471-0528.14543","article-title":"Serous Tubal Intraepithelial Carcinomas Associated with High-grade Serous Ovarian Carcinomas: A Systematic Review","volume":"124","author":"Chen","year":"2017","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev. Res. Phila. Pa."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The Disparate Origins of Ovarian Cancers: Pathogenesis and Prevention Strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAT.0000000000000291","article-title":"The Secondary M\u00fcllerian System, Field Effect, BRCA, and Tubal Fimbria: Our Evolving Understanding of the Origin of Tubo-Ovarian High-Grade Serous Carcinoma and Why Assignment of Primary Site Matters","volume":"47","author":"Singh","year":"2015","journal-title":"Pathology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The Fallopian Tube, \u201cPrecursor Escape\u201d and Narrowing the Knowledge Gap to the Origins of High-Grade Serous Carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The Origin of Ovarian Cancer Species and Precancerous Landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic Landscape and Evolutionary Trajectories of Ovarian Cancer Precursor Lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/PAS.0000000000001283","article-title":"Analysis of Telomere Lengths in P53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer","volume":"43","author":"Asaka","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.4230","article-title":"Distinct Evolutionary Trajectories of Primary High-Grade Serous Ovarian Cancers Revealed through Spatial Mutational Profiling","volume":"231","author":"Bashashati","year":"2013","journal-title":"J. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/humrep\/det340","article-title":"Increased Risk for Ovarian Cancer and Borderline Ovarian Tumours in Subfertile Women with Endometriosis","volume":"28","author":"Buis","year":"2013","journal-title":"Hum. Reprod. Oxf. Engl."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"101700","DOI":"10.1016\/j.canep.2020.101700","article-title":"Increased Association of Ovarian Cancer in Women with Histological Proven Endosalpingiosis","volume":"65","author":"Hermens","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"100542","DOI":"10.1016\/j.xcrm.2022.100542","article-title":"A Multi-Level Investigation of the Genetic Relationship between Endometriosis and Ovarian Cancer Histotypes","volume":"3","author":"Mortlock","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2011.10.001","article-title":"The Association between Endometriosis and Ovarian Cancer: A Review of Histological, Genetic and Molecular Alterations","volume":"124","author":"Munksgaard","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between Endometriosis and Risk of Histological Subtypes of Ovarian Cancer: A Pooled Analysis of Case\u2013Control Studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10815-010-9436-1","article-title":"Endometriosis and Infertility","volume":"27","author":"Bulletti","year":"2010","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis Is a Chronic Systemic Disease: Clinical Challenges and Novel Innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet Br. Ed."},{"key":"ref_66","first-page":"93\u2013U42","article-title":"Metastatic or Embolic Endometriosis, Due to the Menstrual Dissemination of Endometrial Tissue, into the Venous Circulation","volume":"3","author":"Sampson","year":"1927","journal-title":"Am. J. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0015-0282(16)45251-9","article-title":"Endometriosis and The Development of Tuboperitoneal Fistulas After Tubal Ligation","volume":"35","author":"Rock","year":"1981","journal-title":"Fertil. Steril."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0015-0282(16)47778-2","article-title":"Tubal Polyps, Epithelial Inclusions, and Endometriosis after Tubal Sterilization","volume":"41","author":"Donnez","year":"1984","journal-title":"Fertil. Steril."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-Associated Mutations in Endometriosis without Cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2012.05.007","article-title":"Unraveling the Two Entities of Endometrioid Ovarian Cancer: A Single Center Clinical Experience","volume":"126","author":"Mangili","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/15384047.2019.1595278","article-title":"Endometriosis-Associated Ovarian Cancer Is a Single Entity with Distinct Clinicopathological Characteristics","volume":"20","author":"Li","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/ijgc-2022-004072","article-title":"Ovarian Clear Cell Carcinoma: An Overview of Key Histopathologic Features","volume":"33","author":"Taylor","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","article-title":"Clear Cell Carcinoma of the Ovary: A Retrospective Multicentre Experience of 254 Patients with Complete Surgical Staging","volume":"94","author":"Takano","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ygyno.2004.04.004","article-title":"Pure-Type Clear Cell Carcinoma of the Ovary as a Distinct Histological Type and Improved Survival in Patients Treated with Paclitaxel-Platinum-Based Chemotherapy in Pure-Type Advanced Disease","volume":"94","author":"Ho","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2014.03.017","article-title":"Characteristics of Clear Cell Ovarian Cancer Arising from Endometriosis: A Two Center Cohort Study","volume":"133","author":"Scarfone","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.4516","article-title":"Multifocal Endometriotic Lesions Associated with Cancer Are Clonal and Carry a High Mutation Burden","volume":"236","author":"Anglesio","year":"2015","journal-title":"J. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1158\/1078-0432.CCR-20-1268","article-title":"Endometrial Cancer Molecular Risk Stratification Is Equally Prognostic for Endometrioid Ovarian Carcinoma","volume":"26","author":"Talhouk","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41588-022-01254-1","article-title":"Single-Cell Transcriptomic Analysis of Endometriosis","volume":"55","author":"Fonseca","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal Ligation and Risk of Ovarian Cancer Subtypes: A Pooled Analysis of Case-Control Studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/SPV.0000000000000741","article-title":"Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?","volume":"26","author":"Catanzarite","year":"2020","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3747\/co.26.4068","article-title":"Selected Medical Interventions in Women With a Deleterious Brca Mutation: A Population-Based Study in British Columbia","volume":"26","author":"Hanley","year":"2019","journal-title":"Curr. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13053-021-00196-9","article-title":"Risk Reduction Strategies for BRCA1\/2 Hereditary Ovarian Cancer Syndromes: A Clinical Practice Guideline","volume":"19","author":"Jacobson","year":"2021","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_85","first-page":"CD012464","article-title":"Risk-Reducing Bilateral Salpingo-Oophorectomy in Women with BRCA1 or BRCA2 Mutations","volume":"8","author":"Eleje","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_86","first-page":"1027","article-title":"Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses\u2019 Health Study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet. Gynecol. N. Y. 1953"},{"key":"ref_87","first-page":"709","article-title":"Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses\u2019 Health Study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet. Gynecol. N. Y. 1953"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-Term Health Consequences of Premature or Early Menopause and Considerations for Management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Le Page, C., Rahimi, K., K\u00f6bel, M., Tonin, P.N., Meunier, L., Portelance, L., Bernard, M., Nelson, B.H., Bernardini, M.Q., and Bartlett, J.M.S. (2018). Characteristics and Outcome of the COEUR Canadian Validation Cohort for Ovarian Cancer Biomarkers. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4242-8"},{"key":"ref_92","unstructured":"Smith, R., Mettlin, C., and Eyre, H. (2003). Holland-Frei Cancer Medicine, BC Decker. [6th ed.]."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"270.e1","DOI":"10.1016\/j.ajog.2016.10.035","article-title":"The Performance and Safety of Bilateral Salpingectomy for Ovarian Cancer Prevention in the United States","volume":"216","author":"Hanley","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic Salpingectomy: Uptake, Risks, and Complications of a Regional Initiative for Ovarian Cancer Prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"172.e1","DOI":"10.1016\/j.ajog.2018.05.019","article-title":"Extending the Safety Evidence for Opportunistic Salpingectomy in Prevention of Ovarian Cancer: A Cohort Study from British Columbia, Canada","volume":"219","author":"Hanley","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/AOG.0000000000003673","article-title":"Salpingectomy at the Time of Cesarean Delivery: A Systematic Review and Meta-Analysis","volume":"135","author":"Roeckner","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.maturitas.2022.08.002","article-title":"The Effect of Opportunistic Salpingectomy for Primary Prevention of Ovarian Cancer on Ovarian Reserve: A Systematic Review and Meta-Analysis","volume":"166","author":"Gelderblom","year":"2022","journal-title":"Maturitas"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2020.02.005","article-title":"Examining Indicators of Early Menopause Following Opportunistic Salpingectomy: A Cohort Study from British Columbia, Canada","volume":"223","author":"Hanley","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"85.e1","DOI":"10.1016\/j.ajog.2018.10.016","article-title":"Menopausal Symptoms and Surgical Complications after Opportunistic Bilateral Salpingectomy, a Register-Based Cohort Study","volume":"220","author":"Collins","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/AOG.0000000000005118","article-title":"Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis","volume":"141","author":"Wagar","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"106.e1","DOI":"10.1016\/j.ajog.2018.08.032","article-title":"Cost-Effectiveness of Opportunistic Salpingectomy vs Tubal Ligation at the Time of Cesarean Delivery","volume":"220","author":"Venkatesh","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_103","first-page":"338","article-title":"Costs and Benefits of Opportunistic Salpingectomy as an Ovarian Cancer Prevention Strategy","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet. Gynecol. N. Y. 1953"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of Tubal Sterilization Technique on Risk of Serous Epithelial Ovarian and Primary Peritoneal Carcinoma","volume":"135","author":"Handlogten","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal Ligation and Salpingectomy and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors: A Nationwide Case-Control Study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study","volume":"107","author":"Falconer","year":"2015","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ygyno.2023.08.016","article-title":"Risk of Ovarian Cancer after Salpingectomy and Tubal Ligation: Prospects on Histology and Time since the Procedure","volume":"177","author":"Duus","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e2327198","DOI":"10.1001\/jamanetworkopen.2023.27198","article-title":"Salpingectomy and the Risk of Ovarian Cancer in Ontario","volume":"6","author":"Giannakeas","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2018.03.043","article-title":"Opportunistic Prophylactic Salpingectomy for Prevention of Ovarian Cancer: What Do National Societies Advise?","volume":"225","author":"Tomasch","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"E466","DOI":"10.9778\/cmajo.20210219","article-title":"Opportunistic Salpingectomy between 2011 and 2016: A Descriptive Analysis","volume":"10","author":"Hanley","year":"2022","journal-title":"CMAJ Open"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1007\/s00432-023-04578-5","article-title":"Ovarian Cancer Prevention by Opportunistic Salpingectomy Is a New de Facto Standard in Germany","volume":"149","author":"Runnebaum","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/aogs.14507","article-title":"First Step in Implementation of Opportunistic Salpingectomy for Prevention of Ovarian Cancer: Current Care and Its Determinants","volume":"102","author":"Gelderblom","year":"2023","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/1940-6207.CAPR-21-0121","article-title":"Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States","volume":"14","author":"Karia","year":"2021","journal-title":"Cancer Prev. Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Matsuo, K., Chen, L., Matsuzaki, S., Mandelbaum, R.S., Ciesielski, K.M., Silva, J.P., Klar, M., Roman, L.D., Accordino, M.K., and Melamed, A. (2022). Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for Ovarian Cancer Prevention: A Cost-Effectiveness Analysis. Ann. Surg., Publish Ahead of Print.","DOI":"10.1097\/SLA.0000000000005374"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/bjs.11419","article-title":"Prophylactic Salpingectomy for Prevention of Ovarian Cancer at the Time of Elective Laparoscopic Cholecystectomy","volume":"107","author":"Tomasch","year":"2020","journal-title":"Br. J. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.surg.2018.03.024","article-title":"Would Women Accept Opportunistic (Prophylactic) Salpingectomy at the Time of Nongynecologic Surgery to Prevent Development of Ovarian Cancer?","volume":"164","author":"Tomasch","year":"2018","journal-title":"Surgery"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.2023.6979","article-title":"Salpingectomy in Ovarian Cancer Prevention","volume":"329","author":"Stone","year":"2023","journal-title":"JAMA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1158\/1055-9965.EPI-12-1030-T","article-title":"Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer","volume":"22","author":"Pearce","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1055-9965.EPI-17-0315","article-title":"Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions","volume":"27","author":"Kar","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","article-title":"CanRisk Tool\u2014A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants","volume":"30","author":"Carver","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jmedgenet-2021-107904","article-title":"Comprehensive Epithelial Tubo-Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors","volume":"59","author":"Lee","year":"2021","journal-title":"J. Med. Genet."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3802\/jgo.2019.30.e2","article-title":"Factors Influencing Decision-Making around Opportunistic Salpingectomy: A Nationwide Survey","volume":"30","author":"Steenbeek","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"234.e1","DOI":"10.1016\/j.ajog.2021.09.010","article-title":"Primary Prevention of Ovarian Cancer: A Patient Decision Aid for Opportunistic Salpingectomy","volume":"226","author":"Gelderblom","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Gelderblom, M.E., Van Lieshout, L.A.M., Piek, J.M.J., De Hullu, J.A., and Hermens, R.P.M.G. (2021). Patients\u2019 and Professionals\u2019 Perspectives on Implementation of Opportunistic Salpingectomy: A Mixed-Method Study. BMC Health Serv. Res., 21.","DOI":"10.1186\/s12913-021-06767-9"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","article-title":"Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review","volume":"158","author":"Kahn","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2022.04.036","article-title":"Racial and Ethnic Differences in the Adoption of Opportunistic Salpingectomy for Ovarian Cancer Prevention in the United States","volume":"227","author":"Karia","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_127","unstructured":"(2023, August 15). Racial Disparities in Sterilization Procedure Performed at Time of Cesarean Section, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/36351447\/#:~:text=After%20adjusting%20for%20differences%2C%20Black,interval%3A%200.36%2D0.75."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2105\/AJPH.2004.041608","article-title":"STERILIZED in the Name of Public Health: Race, Immigration, and Reproductive Control in Modern California","volume":"95","author":"Stern","year":"2005","journal-title":"Am. J. Public. Health"},{"key":"ref_129","unstructured":"Standing Senate Committee on Human Rights (2023, August 15). Forced and Coerced Sterilization of Persons in Canada. Available online: https:\/\/sencanada.ca\/content\/sen\/committee\/432\/RIDR\/reports\/ForcedSterilization_Report_FINAL_E.pdf."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40985-017-0060-9","article-title":"Forced Sterilization of Women as Discrimination","volume":"38","author":"Patel","year":"2017","journal-title":"Public. Health Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1056\/NEJMp1313325","article-title":"Medicaid Policy on Sterilization\u2014Anachronistic or Still Relevant?","volume":"370","author":"Borrero","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/AOG.0000000000005130","article-title":"Medicaid and Fulfillment of Postpartum Permanent Contraception Requests","volume":"141","author":"Arora","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"397.e1","DOI":"10.1016\/j.ajog.2021.03.032","article-title":"The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and Healthcare Costs: A Call for Universal Insurance Coverage","volume":"225","author":"Naumann","year":"2021","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/12\/741\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:33:41Z","timestamp":1760132021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/12\/741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":133,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["curroncol30120741"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30120741","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}